Newsroom | 64151 results
Sorted by: Latest
-
Samenvatting: Wereldberoemd bloedtransfusiecongres in 2028 in Yokohama
YOKOHAMA, Japan--(BUSINESS WIRE)--Het 2028 Internationale Congres van de International Society of Blood Transfusion (ISBT 2028) vindt plaats in Yokohama van 4 tot 8 juni 2028. Het wordt georganiseerd door ISBT en de Japan Society of Transfusion Medicine and Cell Therapy (JSTMCT). Na drie eerdere internationale (1960, 1996) en regionale congressen (2009) in Japan, keert het evenement na 19 jaar terug naar Japan. De succesvolle kandidatuur van JSTMCT om ISBT 2028 te organiseren werd ondersteund d...
-
Riassunto: Yokohama nel 2028 ospiterà un congresso di fama mondiale sulle emotrasfusioni
YOKOHAMA, Giappone--(BUSINESS WIRE)--Il congresso internazionale 2028 dell'International Society of Blood Transfusion (ISBT 2028) si svolgerà a Yokohama dal 4 all'8 giugno 2028. Organizzato congiuntamente dall'ISBT e dalla Japan Society of Transfusion Medicine and Cell Therapy (JSTMCT), segna il ritorno in Giappone di questo evento a distanza di 19 anni, dopo tre precedenti congressi, sia internazionali (1960 e 1996) che regionali (2009), organizzati nel paese asiatico. In collaborazione con la...
-
Un congrès de renommée mondiale sur la transfusion sanguine se tiendra à Yokohama en 2028
YOKOHAMA, Japon--(BUSINESS WIRE)--Le Congrès international 2028 de la Société internationale de transfusion sanguine (2028 International Congress of the International Society for Blood Transfusion, ISBT 2028) se tiendra à Yokohama du 4 au 8 juin 2028. Organisé conjointement par l’ISBT et la Japan Society of Transfusion Medicine and Cell Therapy (JSTMCT), ce congrès marquera le retour de l’événement au Japon après 19 ans, après trois congrès déjà tenus dans le pays, dont deux internationaux (196...
-
Resumen: El Congreso de Medicina Transfusional reconocido mundialmente se celebrará en Yokohama en 2028
YOKOHAMA, Japón--(BUSINESS WIRE)--El Congreso Internacional 2028 de la International Society of Blood Transfusion (ISBT 2028) se celebrará en Yokohama del 4 al 8 de junio de 2028, y estará organizado conjuntamente por la ISBT y la Japan Society of Transfusion Medicine and Cell Therapy (JSTMCT). Este evento marca el regreso a Japón después de 19 años, tras tres congresos internacionales (1960, 1996) y regionales (2009) celebrados anteriormente en el país. En colaboración con la ciudad de Yokoham...
-
Weltbekannter Blood Transfusion Congress findet 2028 in Yokohama statt
YOKOHAMA, Japan--(BUSINESS WIRE)--Der International Congress of the International Society of Blood Transfusion (ISBT 2028) findet vom 4. bis 8. Juni 2028 in Yokohama statt. Die Veranstaltung wird gemeinsam von der ISBT und der Japan Society of Transfusion Medicine and Cell Therapy (JSTMCT) organisiert und kehrt damit nach 19 Jahren nach Japan zurück, nachdem zuvor bereits drei internationale Kongresse (1960, 1996) und regionale Kongresse (2009) in diesem Land stattgefunden hatten. In Zusammenar...
-
World-renowned Blood Transfusion Congress to Be Held in Yokohama in 2028
YOKOHAMA, Japan--(BUSINESS WIRE)--The 2028 International Congress of the International Society of Blood Transfusion (ISBT 2028) will be held in Yokohama, Japan....
-
Klick Health Sweeps The Creative Floor Awards
LONDON & TORONTO--(BUSINESS WIRE)--Klick Health dominated The Creative Floor Healthcare Awards in London’s East End last night, taking home 30 wins, including 28 campaign honors and the coveted ‘World’s Most Awarded Agency’ title for the second consecutive year. Chief Creative Officer Rich Levy was also inducted into the Hall of Legends, the show’s highest individual accolade, for his enduring impact on healthcare creativity. The Creative Floor Founder Shaheed Peera said, “Rich Levy embodies ev...
-
Endpoints News Announces the 2025 Winners of the Endpoints 11 Awards, Highlighting Biotech’s Most Promising Startups
LAWRENCE, Kan.--(BUSINESS WIRE)--Endpoints News Announces the 2025 Winners of the Endpoints 11 Awards, Highlighting Biotech’s Most Promising Startups...
-
No Difference in Transplant Outcomes Seen for Patients Unlikely to Find a Matched Unrelated Donor When a Donor Search Prognosis Strategy is Used
MINNEAPOLIS--(BUSINESS WIRE)--A study by the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) found that a donor search prognosis-based strategy helps physicians move patients with blood cancers and other blood diseases to hematopoietic cell transplant (HCT) faster, resulting in similar transplant success regardless of likelihood of finding a matched unrelated donor (MUD). Investigators from the consortium of U.S. transplant centers, CIBMTR® (Center for International Blood and Marr...
-
New MindMed Retrospective Study Presented at Psych Congress 2025 Reveals High Rates of Suicidal Ideation (SI) in Adults with Generalized Anxiety Disorder (GAD)
NEW YORK--(BUSINESS WIRE)--Researchers from Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today presented results from a cross-sectional retrospective study of more than 75,000 respondents from the 2022 National Health and Wellness Survey at the Psych Congress 2025. The analysis found that nearly half (48%) of respondents with severe GAD symptoms repo...